Thus, this could lead us to suppose that the activation of ASAH1 worsens lung cancer patients’ survival, mainly due to the activation of fatty acid metabolism, which we already demonstrated to be altered in lung cancer [24], as well as proto-oncogene pathways (Figure 6). This evidence concerns the gene ASAH1 and lung carcinoma.